Logo image of CVNA

CARVANA CO (CVNA) Stock Fundamental Analysis

NYSE:CVNA - New York Stock Exchange, Inc. - US1468691027 - Common Stock - Currency: USD

343.67  -1.88 (-0.54%)

After market: 343.67 0 (0%)

Fundamental Rating

5

CVNA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. CVNA has an excellent financial health rating, but there are some minor concerns on its profitability. CVNA shows excellent growth, but is valued quite expensive already. With these ratings, CVNA could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CVNA had positive earnings in the past year.
In the past year CVNA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CVNA reported negative net income in multiple years.
In multiple years CVNA reported negative operating cash flow during the last 5 years.
CVNA Yearly Net Income VS EBIT VS OCF VS FCFCVNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

CVNA has a Return On Assets of 4.48%. This is in the better half of the industry: CVNA outperforms 66.12% of its industry peers.
With an excellent Return On Equity value of 26.46%, CVNA belongs to the best of the industry, outperforming 82.64% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 14.11%, CVNA belongs to the top of the industry, outperforming 82.64% of the companies in the same industry.
Industry RankSector Rank
ROA 4.48%
ROE 26.46%
ROIC 14.11%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVNA Yearly ROA, ROE, ROICCVNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Profit Margin, with a value of 2.68%, CVNA is in the better half of the industry, outperforming 65.29% of the companies in the same industry.
CVNA's Operating Margin of 8.42% is amongst the best of the industry. CVNA outperforms 80.17% of its industry peers.
CVNA has a worse Gross Margin (21.65%) than 79.34% of its industry peers.
CVNA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.42%
PM (TTM) 2.68%
GM 21.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
CVNA Yearly Profit, Operating, Gross MarginsCVNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CVNA is still creating some value.
The number of shares outstanding for CVNA has been increased compared to 1 year ago.
Compared to 5 years ago, CVNA has more shares outstanding
The debt/assets ratio for CVNA has been reduced compared to a year ago.
CVNA Yearly Shares OutstandingCVNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CVNA Yearly Total Debt VS Total AssetsCVNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 8.48 indicates that CVNA is not in any danger for bankruptcy at the moment.
CVNA has a Altman-Z score of 8.48. This is amongst the best in the industry. CVNA outperforms 98.35% of its industry peers.
The Debt to FCF ratio of CVNA is 5.94, which is a neutral value as it means it would take CVNA, 5.94 years of fcf income to pay off all of its debts.
CVNA has a better Debt to FCF ratio (5.94) than 62.81% of its industry peers.
A Debt/Equity ratio of 3.55 is on the high side and indicates that CVNA has dependencies on debt financing.
CVNA's Debt to Equity ratio of 3.55 is on the low side compared to the rest of the industry. CVNA is outperformed by 76.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 5.94
Altman-Z 8.48
ROIC/WACC1.53
WACC9.21%
CVNA Yearly LT Debt VS Equity VS FCFCVNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

CVNA has a Current Ratio of 3.81. This indicates that CVNA is financially healthy and has no problem in meeting its short term obligations.
CVNA's Current ratio of 3.81 is amongst the best of the industry. CVNA outperforms 95.04% of its industry peers.
CVNA has a Quick Ratio of 2.70. This indicates that CVNA is financially healthy and has no problem in meeting its short term obligations.
CVNA has a better Quick ratio (2.70) than 96.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 2.7
CVNA Yearly Current Assets VS Current LiabilitesCVNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.11% over the past year.
The Revenue has grown by 32.23% in the past year. This is a very strong growth!
The Revenue has been growing by 28.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)260.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%556.52%
Revenue 1Y (TTM)32.23%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%38.26%

3.2 Future

CVNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.89% yearly.
The Revenue is expected to grow by 18.05% on average over the next years. This is quite good.
EPS Next Y189.36%
EPS Next 2Y93.02%
EPS Next 3Y64.31%
EPS Next 5Y42.89%
Revenue Next Year31.64%
Revenue Next 2Y26.65%
Revenue Next 3Y25.17%
Revenue Next 5Y18.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVNA Yearly Revenue VS EstimatesCVNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
CVNA Yearly EPS VS EstimatesCVNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 10 -10

3

4. Valuation

4.1 Price/Earnings Ratio

CVNA is valuated quite expensively with a Price/Earnings ratio of 120.59.
CVNA's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CVNA is valued quite expensively.
CVNA is valuated quite expensively with a Price/Forward Earnings ratio of 58.76.
Based on the Price/Forward Earnings ratio, CVNA is valued a bit more expensive than the industry average as 61.98% of the companies are valued more cheaply.
CVNA is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 120.59
Fwd PE 58.76
CVNA Price Earnings VS Forward Price EarningsCVNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

66.94% of the companies in the same industry are cheaper than CVNA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVNA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 77.55
EV/EBITDA 50.27
CVNA Per share dataCVNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CVNA's earnings are expected to grow with 64.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y93.02%
EPS Next 3Y64.31%

0

5. Dividend

5.1 Amount

CVNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARVANA CO

NYSE:CVNA (7/11/2025, 8:04:00 PM)

After market: 343.67 0 (0%)

343.67

-1.88 (-0.54%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners91.99%
Inst Owner Change0.02%
Ins Owners2.83%
Ins Owner Change-0.88%
Market Cap73.59B
Analysts77.04
Price Target307.47 (-10.53%)
Short Float %8.23%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)110.73%
Min EPS beat(2)90.71%
Max EPS beat(2)130.76%
EPS beat(4)4
Avg EPS beat(4)169.37%
Min EPS beat(4)90.71%
Max EPS beat(4)305.93%
EPS beat(8)7
Avg EPS beat(8)111.76%
EPS beat(12)9
Avg EPS beat(12)81.47%
EPS beat(16)10
Avg EPS beat(16)62.17%
Revenue beat(2)2
Avg Revenue beat(2)4.59%
Min Revenue beat(2)4.24%
Max Revenue beat(2)4.94%
Revenue beat(4)4
Avg Revenue beat(4)4.01%
Min Revenue beat(4)3.05%
Max Revenue beat(4)4.94%
Revenue beat(8)6
Avg Revenue beat(8)4.07%
Revenue beat(12)6
Avg Revenue beat(12)0.45%
Revenue beat(16)10
Avg Revenue beat(16)3%
PT rev (1m)17.58%
PT rev (3m)18.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)43.33%
EPS NY rev (1m)-1.59%
EPS NY rev (3m)60%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)8.25%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)6.37%
Valuation
Industry RankSector Rank
PE 120.59
Fwd PE 58.76
P/S 4.96
P/FCF 77.55
P/OCF 70.16
P/B 48.93
P/tB 50.17
EV/EBITDA 50.27
EPS(TTM)2.85
EY0.83%
EPS(NY)5.85
Fwd EY1.7%
FCF(TTM)4.43
FCFY1.29%
OCF(TTM)4.9
OCFY1.43%
SpS69.32
BVpS7.02
TBVpS6.85
PEG (NY)0.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.48%
ROE 26.46%
ROCE 16.6%
ROIC 14.11%
ROICexc 18.68%
ROICexgc 18.8%
OM 8.42%
PM (TTM) 2.68%
GM 21.65%
FCFM 6.39%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
F-Score7
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 5.94
Debt/EBITDA 3.45
Cap/Depr 33.78%
Cap/Sales 0.67%
Interest Coverage 5.53
Cash Conversion 67.85%
Profit Quality 238.44%
Current Ratio 3.81
Quick Ratio 2.7
Altman-Z 8.48
F-Score7
WACC9.21%
ROIC/WACC1.53
Cap/Depr(3y)83.57%
Cap/Depr(5y)253.76%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%556.52%
EPS Next Y189.36%
EPS Next 2Y93.02%
EPS Next 3Y64.31%
EPS Next 5Y42.89%
Revenue 1Y (TTM)32.23%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%38.26%
Revenue Next Year31.64%
Revenue Next 2Y26.65%
Revenue Next 3Y25.17%
Revenue Next 5Y18.06%
EBIT growth 1Y551.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.74%
EBIT Next 3Y48%
EBIT Next 5Y32.3%
FCF growth 1Y184.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y231.62%
OCF growth 3YN/A
OCF growth 5YN/A